April 2014
International Journal of Pharma & Bio Sciences;Apr2014, Vol. 5 Issue 2, pP-300
Academic Journal
Docetaxel, an anti-mitotic chemotherapeutic agent, is mainly used for the treatment of various cancers. The objective of this study was to evaluate the antitumor activity of docetaxel-loaded-microemulsion in A549 non-small cell lung cancer and HCT 116 colon cancer cells. The safe effect of the formula was evaluated in HFS human foreskin cells. It has been found that the storage of the drug in the microemulsion formulation for around two weeks (O-ME) did not affect the toxicity of the drug formulations against the erythrocytes as the hemolysis activities of 1mg/ml of both of freshly prepared docetaxelloaded- microemulsion (F-ME) and O-ME were 36 ± 7.61 and 32.15 ± 6.32, respectively. The cytotoxicity screening revealed that 5μM of F-ME and O-ME were more cytotoxic than 5 μM of Taxotere by two folds when subjected unto A549 and HCT 116 cells and were less than 5 μM of Taxotere by approximately one and half folds when administered into HFS cells. Formulating the docetaxel in a microemulsion formula improved its efficiency besides reducing its side effect.


Related Articles

  • Symmetrical Derivatives of C2-Substituted Pyrrolo[2,3-f]quinolines:Synthesis, Cytotoxicity and Drug Delivery Studies. Tsotinis, Andrew; Vlachou, Marilena; Gerasimopoulou, Maria; Eikosipentaki, Aphrodite; Ioannidis, Constantine; Klouvidaki, Anna; Afroudakis, Pandelis A.; Moreau, Dimitri; Roussakis, Christos // Letters in Drug Design & Discovery;Mar2007, Vol. 4 Issue 2, p87 

    The synthesis, pharmacological properties and delivery characteristics in simulated aqueous gastric fluid of a series of symmetrical nitrogenated C2-substituted pyrrolo[2,3-f]quinolines are described. The cytotoxicity of the target molecules (5a-h) was evaluated in the human non-small lung...

  • Crocetin induces cytotoxicity and enhances vincristine-induced cancer cell death via p53-dependent and -independent mechanisms. Zhong, Ying-jia; Shi, Fang; Zheng, Xue-lian; Wang, Qiong; Yang, Lan; Sun, Hong; He, Fan; Zhang, Lin; Lin, Yong; Qin, Yong; Liao, Lin-chuan; Wang, Xia // Acta Pharmacologica Sinica;Dec2011, Vol. 32 Issue 12, p1529 

    Aim:To investigate the anticancer effect of crocetin, a major ingredient in saffron, and its underlying mechanisms.Methods:Cervical cancer cell line HeLa, non-small cell lung cancer cell line A549 and ovarian cancer cell line SKOV3 were treated with crocetin alone or in combination with...

  • Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer. Takezawa, K.; Okamoto, I.; Okamoto, W.; Takeda, M.; Sakai, K.; Tsukioka, S.; Kuwata, K.; Yamaguchi, H.; Nishio, K.; Nakagawa, K. // British Journal of Cancer;5/10/2011, Vol. 104 Issue 10, p1594 

    Background:Although a high level of thymidylate synthase (TS) expression in malignant tumours has been suggested to be related to a reduced sensitivity to the antifolate drug pemetrexed, no direct evidence for such an association has been demonstrated in non-small cell lung cancer (NSCLC). We...

  • Sensitivity of Non-Small-Cell Lung Cancer Cell Lines Established from Patients Treated with Prolonged Infusions of Paclitaxel. Fujishita, Takashi; Loda, Massimo; Turner, Ross E.; Gentler, Marinshine; Kashii, Tatsuhiko; Breathnach, Oscar S.; Johnson, Bruce E. // Oncology;2003, Vol. 64 Issue 4, p399 

    Objective: Regimens with prolonged infusions of taxanes have been developed for patients with cancer to overcome drug resistance. Our objective of the present study was to examine the impact of prolonged exposure on the cytotoxicity of taxanes against non-small-cell lung carcinoma (NSCLC) cell...

  • Platinum anticancer agents and antidepressants: desipramine enhances platinum-based cytotoxicity in human colon cancer cells. Kabolizadeh, Peyman; Engelmann, Brigitte; Pullen, Nicholas; Stewart, Jennifer; Ryan, John; Farrell, Nicholas // Journal of Biological Inorganic Chemistry;Jan2012, Vol. 17 Issue 1, p123 

    A unique synergistic effect on platinum drug cytotoxicity is noted in the presence of the tricyclic antidepressant desipramine. Desipramine is used for treating neuropathic pain, particularly in prostate cancer patients. The clinically used drugs cisplatin ( cis-[PtCl(NH)]), oxaliplatin...

  • Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues. Buß, Irina; Kalayda, Ganna; Lindauer, Andreas; Reithofer, Michael; Galanski, Markus; Keppler, Bernhard; Jaehde, Ulrich // Journal of Biological Inorganic Chemistry;May2012, Vol. 17 Issue 5, p699 

    The purpose of this study was to systematically investigate the relationships between reactivity, cellular accumulation, and cytotoxicity of a panel of oxaliplatin analogues with different leaving groups in human carcinoma cells. The reactivity of the complexes towards the nucleotides...

  • High Glucose Modulates Antiproliferative Effect and Cytotoxicity of 5-Fluorouracil in Human Colon Cancer Cells. Ma, Yi-Shing; Yang, I-Ping; Tsai, Hsiang-Lin; Huang, Ching-Wen; Juo, Suh-Hang Hank; Wang, Jaw-Yuan // DNA & Cell Biology;Feb2014, Vol. 33 Issue 2, p64 

    5-Fluorouracil (5-FU)-based chemotherapy is widely used for the treatment of colorectal cancer (CRC). While optimal doses of 5-FU are generally established based on a patient's estimated body surface area, the plasma concentrations of 5-FU vary among patients. In addition, hyperglycemia in...

  • Effect of Cellular Location of Human Carboxylesterase 2 on CPT-11 Hydrolysis and Anticancer Activity. Hsieh, Yuan-Ting; Lin, Hsuan-Pei; Chen, Bing-Mae; Huang, Ping-Ting; Roffler, Steve R. // PLoS ONE;10/28/2015, Vol. 10 Issue 10, p1 

    CPT-11 is an anticancer prodrug that is clinically used for the treatment of metastatic colorectal cancer. Hydrolysis of CPT-11 by human carboxylesterase 2 (CE2) generates SN-38, a topoisomerase I inhibitor that is the active anti-tumor agent. Expression of CE2 in cancer cells is under...

  • Insulin Decreases Therapeutic Efficacy in Colon Cancer Cell Line HT29 Via the Activation of the PI3K/Akt Pathway. Jiezhong Chen; Katsifis, Andrew; Changhua Hu; Xu-Feng Huang // Current Drug Discovery Technologies;Jun2011, Vol. 8 Issue 2, p119 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics